scorecardresearch
Wednesday, November 6, 2024
TopicDiabetes

Topic: Diabetes

This is why some young Indians are at higher risk of Covid complications

Metabolic disorders are increasingly common among younger Indians, so the age at which Covid-19 becomes a higher risk could be much lower than 65-plus.

US drug regulator approves use of diabetes drug, also sold in India, to prevent heart attack

The drug Farxiga is sold in India by UK-based pharma giant AstraZeneca under the brand name ‘Forxiga’ to treat type 2 diabetes.

Stock of insulin, cardiac drugs dips ‘below normal’ levels as India panic buys in lockdown

States and union territories have been instructed to ensure production and supply of cardiac and anti-diabetic medicines, including insulin.

Covid-19 with diabetes is more deadly. Here’s why you must control it during lockdown and how

Endocrinologist Ambrish Mithal says if you are smart, follow the basics, and adapt to simple internet-based technology, you will emerge a winner.

No proof that drugs for heart ailments, diabetes are increasing severity of Covid-19: ICMR

ICMR has come to the conclusion ‘after review of the available information and deriving the consensus of various scientific societies and expert groups’.

Avoid ibuprofen, ICMR tells diabetes, hypertension, heart patients in Covid-19 FAQs

The advice follows a letter published in Lancet Respiratory Medicine that suggests ibuprofen can ‘aggravate’ Covid-19 infection in diabetes and hypertension patients. 

What is comorbidity — the factor that likely led to 3 COVID-19 deaths in India

All three Indians who have died of COVID-19 had underlying health conditions that are believed to have compromised their fight against the disease.

What patients of diabetes, asthma need to do to stay safe from COVID-19

Early clinical profile of COVID-19 suggests severe manifestation in people suffering from diabetes, cardiovascular conditions and lung diseases like asthma.  

Price controls more important than ever for drugs used to treat prevalent diseases: Report

The report published by Brookings India Tuesday says price control is a double-edged sword that should be carefully used for growth of industry & interest of consumers.

This app is helping patients make lifestyle changes to deal with diseases like diabetes

Founded by a former employee of a venture capitalist firm, Wellthy acts as a gatekeeper between patients and doctors in aid of traditional healthcare.

On Camera

What Trump-Harris result could mean for India in key areas, from geopolitics to trade & immigration

India cannot be blasé about change in any important capital in the world. Let's look at five key areas where US policy matters for India and how it may vary between Harris and Trump.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

Rifles slung upside down, on ponies. Indian troops go on their 1st patrol in Depsang since 2020

Troops patrolled up to Patrolling Point (PP) 10 on Monday. Though there are PP 10, 11, 12, 12A & 13 in Depsang Plains, it was decided that only one or two PPs would be patrolled.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.